PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bayer
Related studies linked through entity extraction aliases.
Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Research Study for Patients With Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting
- Status
- TERMINATED
- Phase
- PHASE3
A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
- Status
- COMPLETED
- Phase
- PHASE3
BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
BAY43-9006 - Phase II in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2